Return to search

The Research In The SCM Of Bio-pharmaceutical Industry In Taiwan¢wA Case Study Of LLY

¡@¡@Although the Bio-pharmaceutical industry in Taiwan is less then 1% in worldwide medical market¡CAlmost 150 Bio-pharmaceutical companies in Taiwan were met the cGMP standard, yet limited on the R&D human resources and the capital size ¡Amost of the companies all focus on the manufacturing of Generic products.
¡@¡@As the Internationalize and Globalize were mainstreams for all Pharmaceutical industries. We need to take this into consideration that how we increase Taiwan¡¦s competitiveness, and win out over the other industry in the international alliance. And should we improve any weakness? Efficiency, Inventory, or customer needs?¡@¡@
¡@¡@So far¡Mbecause of the conflict of the Regulation requirements¡M. Most Bio-industry was not using the ERP/SCM for the management¡C In this study¡MWe hope to provide an actual example for the other Bio-industry as reference¡Mand then as an application model to improve the competitiveness of Taiwan Bio-pharmaceutical industry.¡@¡@
¡@¡@During the dissertation, we discover the monograph rational of ERP/SCM, and consider the regulation limited when follow the SCM model to analyze the process suitability and performance for Bio-pharmaceutical Company.
¡@¡@As result, we know that the ERP/MRP-II system or Supply chain management was necessary to the Bio-pharmaceutical industry.

Identiferoai:union.ndltd.org:NSYSU/oai:NSYSU:etd-0804104-055420
Date04 August 2004
CreatorsChen, Yung-Yi
ContributorsBih-Shiaw Jaw, Yueh H. Chen, Iuan-Yuan Lu, Hsien-Tang Tsai
PublisherNSYSU
Source SetsNSYSU Electronic Thesis and Dissertation Archive
LanguageCholon
Detected LanguageEnglish
Typetext
Formatapplication/pdf
Sourcehttp://etd.lib.nsysu.edu.tw/ETD-db/ETD-search/view_etd?URN=etd-0804104-055420
Rightsunrestricted, Copyright information available at source archive

Page generated in 0.0016 seconds